Gardasil royalties are about 20% of CSL's profit, and these are mooted to fall about 20%, and hence the negative impact is some 4%. The market has over reacted to the news that the USA licensee of Gardasil had lowered sales forecasts.
The foregoing arithmetic is a rough approximation, and 4% might be too high, but the thrust of what I write here is probably correct.
Pioupiou
gardasil vaccine eradicating hpv infections, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$305.54 |
Change
-4.850(1.56%) |
Mkt cap ! $147.6B | |||
| Open | High | Low | Value | Volume |
| $307.68 | $309.50 | $305.54 | $259.6M | 847.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 640 | $305.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $306.30 | 200 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |